IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

/PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, today announced its financial...

Related Keywords

Canada ,Germany ,Jerusalem ,Israel General ,Israel ,Toronto ,Ontario ,German ,Israeli ,Canadian ,Oranim Pharm ,Oren Shuster ,Sde Avraham ,Adjupharm Gmb ,Vironna Pharm ,Company Contact ,Company Israeli ,Marketing Ltd ,Panaxia Logistics Ltd ,Im Cannabis Corp ,Trichome Financial Corp ,Panaxia Labs Israel Ltd ,Herbs Ltd ,Canadian Securities Exchange ,Rosen High Way Ltd ,Prnewswire Im Cannabis Corp ,Ra Yarok Pharm Ltd ,Panaxia Pharmaceutical Industries Israel Ltd ,Source Im Cannabis Corp ,Acquisition Corp ,Holdings Ltd ,Nutraceuticals Inc ,Nasdaq ,Oranim Plus Pharm Ltd ,Ontario Superior Court ,Chief Executive Officer ,Continuing Operations ,Dried Flower ,Administrative Expenses ,Marketing Expenses ,Discontinued Operations ,Diluted Loss ,Cash Equivalents ,Revoly Trading ,Pharm Ltd ,Panaxia Pharmaceutical Industries Israel ,Panaxia Labs Israel ,Focus Medical ,Canadian Companie Creditors Arrangement Act ,Annual Report ,Focus Medical Herbs ,Adjupharm Gmbh ,Trichome Financial ,Highland Grow ,Eastern Europe ,Gross Margin ,Share Consolidation ,